×
-0.013681592039801 -0.0211442786069653 -0.0112064676616916 -0.0261194029850747 -0.0379353233830846 -0.00559701492537324 0.00497512437810935 0.0199004975124378
Stockreport

Veracyte Announces Anthem Coverage for the Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis

VERACYTE (VCYT)  More Company Research Source: PR Newswire
Last veracyte earnings: 2/27 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.veracyte.com/investor-relations
PDF SOUTH SAN FRANCISCO, Calif., May 18, 2017 /PRNewswire/ --  Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic uncertainty, today announced that Anthem, Inc., an independent Blues plan and one of the nation's largest health benefits companies, has issued a positive coverage policy for Veracyte's Afirma Gene Expression Classifier (GEC) for use in thyroid cancer diagnosis. The policy renders the genomic test a medically necessary benefit for Anthem's approximately 40 million members, effective immediately. The Afirma GEC is the only genomic test for use in thyroid cancer diagnosis to receive such a designation in the plan's new coverage policy.The Afirma GEC is used to identify patients with benign thyroid nodules among those whose fine needle aspiration (FNA) biopsy results are indeterminate following traditional cytopathology review, so that they may avoid an unnecessary diagnostic surgery. [Read more]

IMPACT SNAPSHOT EVENT TIME: VCYT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS